Literature DB >> 26696400

Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.

Tsukasa Saida1, Yumiko Oishi Tanaka2, Koji Matsumoto3, Toyomi Satoh3, Hiroyuki Yoshikawa4, Manabu Minami2.   

Abstract

Ovarian cancer is the seventh most common cancer diagnosis among women worldwide. The International Federation of Gynecology and Obstetrics recently significantly revised staging criteria for cancer of the ovary. The latest revision was based on the concept that high-grade serous tubal intraepithelial carcinoma (STIC) may be the origin of some high-grade serous carcinomas of the ovary and peritoneum. Therefore, staging criteria for the ovary, fallopian tube, and peritoneum have been unified. Understanding this background and other important revised points are essential for radiologists concerned with imaging diagnosis in gynecologic oncology. Through this review, we introduce the STIC theory and show examples of diseases in accordance with the new staging criteria based on magnetic resonance imaging (MRI) and computed tomography (CT) results.

Entities:  

Keywords:  Ovarian cancer; STIC; Serous carcinoma; Staging

Mesh:

Year:  2015        PMID: 26696400     DOI: 10.1007/s11604-015-0513-3

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  26 in total

1.  Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B.

Authors:  G Ferrandina; G Scambia; F Legge; M Petrillo; V Salutari
Journal:  Gynecol Oncol       Date:  2007-07-05       Impact factor: 5.482

2.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum.

Authors:  Jaime Prat
Journal:  Int J Gynaecol Obstet       Date:  2013-10-22       Impact factor: 3.561

3.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

4.  The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.

Authors:  Ram Eitan; Douglas A Levine; Nadeem Abu-Rustum; Yukio Sonoda; Jae N Huh; Corinna C Franklin; Tobey A Stevens; Richard R Barakat; Dennis S Chi
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

Review 5.  Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.

Authors:  Neeraj Lalwani; Srinivasa R Prasad; Raghunandan Vikram; Alampady K Shanbhogue; Phyllis C Huettner; Najla Fasih
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

6.  Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Angelo Maggioni; Neville Hacker; Fabio Landoni; Sven Ackermann; Elio Campagnutta; Karl Tamussino; Raimund Winter; Antonio Pellegrino; Stefano Greggi; Roberto Angioli; Natalina Manci; Giovanni Scambia; Tiziana Dell'Anna; Roldano Fossati; Irene Floriani; Rita S Rossi; Roberto Grassi; Giuseppe Favalli; Francesco Raspagliesi; Diana Giannarelli; Luca Martella; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2005-04-20       Impact factor: 13.506

7.  The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival.

Authors:  K Kanazawa; T Suzuki; M Tokashiki
Journal:  Gynecol Oncol       Date:  1999-05       Impact factor: 5.482

8.  Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients.

Authors:  T Onda; H Yoshikawa; T Yasugi; M Mishima; S Nakagawa; M Yamada; K Matsumoto; Y Taketani
Journal:  Cancer       Date:  1998-10-15       Impact factor: 6.860

9.  Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer.

Authors:  Su-Jin Baek; Jeong-Yeol Park; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2008-12-29       Impact factor: 4.401

10.  ACR appropriateness criteria staging and follow-up of ovarian cancer.

Authors:  Donald G Mitchell; Marcia C Javitt; Phyllis Glanc; Genevieve L Bennett; Douglas L Brown; Theodore Dubinsky; Mukesh G Harisinghani; Robert D Harris; Neil S Horowitz; Pari V Pandharipande; Harpreet K Pannu; Ann E Podrasky; Henry D Royal; Thomas D Shipp; Cary Lynn Siegel; Lynn Simpson; Jade J Wong-You-Cheong; Carolyn M Zelop
Journal:  J Am Coll Radiol       Date:  2013-11       Impact factor: 5.532

View more
  6 in total

1.  SIX1 is overexpressed in endometrial carcinoma and promotes the malignant behavior of cancer cells through ERK and AKT signaling.

Authors:  Xiaochuan Xin; Yue Li; Xianghong Yang
Journal:  Oncol Lett       Date:  2016-09-07       Impact factor: 2.967

2.  Prognostic and clinicopathological significance of Cacna2d1 expression in epithelial ovarian cancers: a retrospective study.

Authors:  Dandan Yu; Ruth Holm; Mariusz Adam Goscinski; Claes G Trope; Jahn M Nesland; Zhenhe Suo
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

3.  Bilateral Ovarian Tumors on MRI: How Should We Differentiate the Lesions?

Authors:  Naoko Mukuda; Shinya Fujii; Chie Inoue; Takeru Fukunaga; Tetsuro Oishi; Tasuku Harada; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2018-06-18       Impact factor: 1.641

4.  A prognostic system for epithelial ovarian carcinomas using machine learning.

Authors:  Philip M Grimley; Zhenqiu Liu; Kathleen M Darcy; Matthew T Hueman; Huan Wang; Li Sheng; Donald E Henson; Dechang Chen
Journal:  Acta Obstet Gynecol Scand       Date:  2021-03-18       Impact factor: 4.544

5.  ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma.

Authors:  Liang Chen; Mei-Mei Liu; Hui Liu; Dan Lu; Xiao-Dan Zhao; Xue-Jing Yang
Journal:  Onco Targets Ther       Date:  2016-11-14       Impact factor: 4.147

6.  Primary Fallopian Tube Carcinoma: A Case Report and Literature Review.

Authors:  Meral Rexhepi; Elizabeta Trajkovska; Hysni Ismaili; Florin Besimi; Nagip Rufati
Journal:  Open Access Maced J Med Sci       Date:  2017-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.